Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Unity Biotechnology expands Phase I trial of UBX0101 for OA

Histopathology of osteoarthrosis of a knee joint in an elderly female patient. Credit: KGH.

  • Unity Biotechnology

Go Top